HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

Abstract : Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder due to selective loss of motor neurons (MNs). Mutations in the fused in sarcoma (FUS) gene can cause both juvenile and late onset ALS. We generated and characterized induced pluripotent stem cells (iPSCs) from ALS patients with different FUS mutations, as well as from healthy controls. Patient-derived MNs show typical cytoplasmic FUS pathology, hypoexcitability, as well as progressive axonal transport defects. Axonal transport defects are rescued by CRISPR/Cas9-mediated genetic correction of the FUS mutation in patient-derived iPSCs. Moreover, these defects are reproduced by expressing mutant FUS in human embryonic stem cells (hESCs), whereas knockdown of endogenous FUS has no effect, confirming that these pathological changes are mutant FUS dependent. Pharmacological inhibition as well as genetic silencing of histone deacetylase 6 (HDAC6) increase α-tubulin acetylation, endo-plasmic reticulum (ER)–mitochondrial overlay, and restore the axonal transport defects in patient-derived MNs.
Type de document :
Article dans une revue
Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.394 - 405. 〈https://www.nature.com/articles/s41467-017-00911-y〉. 〈10.1038/s41467-017-00911-y〉
Liste complète des métadonnées

Littérature citée [62 références]  Voir  Masquer  Télécharger

https://hal.sorbonne-universite.fr/hal-01628414
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : vendredi 3 novembre 2017 - 14:17:14
Dernière modification le : mercredi 21 mars 2018 - 18:57:51
Document(s) archivé(s) le : dimanche 4 février 2018 - 13:43:52

Fichier

s41467-017-00911-y.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

UPMC | ICM

Citation

Wenting Guo, Maximilian Naujock, Laura Fumagalli, Tijs Vandoorne, Pieter Baatsen, et al.. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.394 - 405. 〈https://www.nature.com/articles/s41467-017-00911-y〉. 〈10.1038/s41467-017-00911-y〉. 〈hal-01628414〉

Partager

Métriques

Consultations de la notice

298

Téléchargements de fichiers

34